Page 83 - Sohini Das

India gets third Covid-19 vaccine as SEC clears Russia's Sputnik V

Final nod from DCGI soon, jab likely at $3/dose

Expert panel recommends approval to Russia's Sputnik V Covid-19 vaccine

Now, the Drugs Controller General of India DCGI will consider this recommendation and decide whether to grant Sputnik V approval for restricted emergency use in India

Second Covid-19 wave: Govt releases vaccines; not enough, says Maharashtra

One of the largest government-run vaccination sites in Mumbai on the Bandra Kurla Complex grounds has only 350 vaccine doses left

Remdesivir output to be ramped up as Covid-19 cases rise sharply

Zydus had recently also slashed prices of its remdesivir brand Remdac to Rs 899 per dose

Second Covid wave: Fatalities threaten to be worse this time, shows data

Deaths due to Covid-19 usually happen two to three weeks after the diagnosis of the disease, according to research and doctors' accounts

AstraZeneca has sent us legal notice for vaccine supply delay: Poonawalla

For the next one or two months, we will be prioritising supplies only to India based on the request of the government and also depending on the needs of our people, said Poonawalla

Serum Institute, Bharat Biotech to speed up Covid-19 vaccine production

This comes after govt panel visits facilities of SII and Bharat Biotech

Panacea Biotec to make 100 mn doses of Sputnik V for global markets

More players like Serum Institute expected to join the fray to make Sputnik V

Weekend lockdown, night curfew in Maharashtra as Covid-19 cases surge

Stricter curbs from Monday; Mumbai civic authorities brace for 10,000 daily cases from next week as available beds in hospitals dry up. The city reported 9,108 cases on Sunday

Serum Institute may apply to sell Covid-19 vaccine Covishield commercially

No Covid vaccine in the world has marketing authorisation allowing sales in private market

Expert panel defers decision on Sputnik V Covid-19 vaccine, wants more data

Details of -25°C cold chain plan sought

Wait for Sputnik V Covid-19 vaccine may get over in a few weeks: DRL

"We expect to get the approval in the next few weeks," said Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy's Laboratories (DRL)

Bharat Biotech, CSIR collaborate to make raw material for vaccines

India now imports adjuvants and other chemicals for vaccine manufacturing

Covid-19 vaccination: COVAX in talks with govt to ensure speedy deliveries

SII is committed to supplying 200 million doses to the collaboration

Second Covid-19 wave: Primary health centres see a rush for vaccine

On ground, manpower concern as drive expands to rural, semi-urban areas

India delays big exports of AstraZeneca vaccine as Covid-19 cases surge

India is, however, not officially banning Covid-19 vaccine exports. "This is a temporary move until the supply situation stabilises in the country," said a person close to the development

Covaxin manufacturing may get a booster shot as demand for vaccines grows

Bharat Biotech also has another site at Bengaluru that is currently making vaccines other than Covaxin

Supply slipping, Centre to speed up Covid-19 vaccine delivery to states

Vaccine makers asked to send more doses to central government on priority

States on overdrive to reduce vaccine wastage as Covid-19 cases rise

Experts say controlling spoilage with 10-dose vials may give vax drive a shot in the arm

Will supply more doses of AstraZeneca vaccine to UK later, says Serum

Senior officials in New Delhi confirmed that there was no ban on exports from India, and no plans to do so either.